CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children

被引:14
|
作者
de Souza, PR
Arraes, LC
de Lima, JL
Bruneska, D
Milanese, M
Crovella, S [1 ]
机构
[1] Univ Fed Pernambuco, LIKA, Recife, PE, Brazil
[2] IMIP, Recife, PE, Brazil
[3] Univ Trieste, Dept Dev & Reprod Sci, I-34137 Trieste, Italy
关键词
CCR5; promoter; polymorphisms; HIV-1; vertical transmission;
D O I
10.1016/j.jri.2005.09.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The frequencies of four CCR5 promoter polymorphisms, and of the Delta 32 deletion, have been evaluated in Brazilian HIV-1 positive (HIV+) and HIV-1 negative (HIV-) children, both born from HIV-1 positive mothers and healthy controls (HC), with the aim of investigating whether CCR5 polyrnorphisms could be associated to vertical transmission of HIV-1. One hundred and six HIV-1 positive children and 70 HIV-1 negative children were enrolled from impoverished areas of Recife (Brazil). We recruited also as healthy controls 104 uninfected children from the same ethnic background, matched for age and known to be not at risk for HIV-1 infection. CCR5 polymorphisms were detected by PCR amplification and direct sequencing. Although no significative divergence was found for CCR5 Delta 32, CCR5-59356-C/T and CCR5-59653 C/T polymorphisms, the frequency of CCR5-59353-T/C and CCR5-59402-A/G genotypes differed among HIV+, HIV- and HC children. The presence of the CCR5-59353-TT genotype indicated a trend for increased risk of vertical transmission of HIV-1 infection in Brazilian children, while the presence of the CCR5-59402-AA genotype is suggestive for a protective effect against HIV-1 vertical transmission. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 50 条
  • [41] A haplotype in the CCR5 gene promoter was associated with the susceptibility to HIV-1 infection in a northern Chinese population
    Xu, Lidan
    Qiao, Yuandong
    Zhang, Xuelong
    Sun, Haiming
    Wang, Jingwei
    Sun, Donglin
    Jia, Xueyuan
    Shen, Chao
    Zhao, Yanling
    Jin, Yan
    Yu, Yang
    Ling, Hong
    Wang, Kaili
    Fu, Songbin
    [J]. MOLECULAR BIOLOGY REPORTS, 2011, 38 (01) : 327 - 332
  • [42] Effects of CCR5 genetic polymorphism and HIV-1 subtype in antiretroviral response in Brazilian HIV-1-infected patients
    Accetturi, CA
    Pardini, R
    Pinto, GHN
    Turcato, G
    Lewi, DS
    Diaz, RS
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (04): : 399 - 400
  • [43] CCR5 promoter region polymorphisms in systemic lupus erythematosus
    Schauren, Juliana da Silveira
    de Oliveira, Amanda Henrique
    Consiglio, Camila Rosat
    Monticielo, Odirlei Andre
    Xavier, Ricardo Machado
    Nunes, Natalia Schneider
    Ellwanger, Joel Henrique
    Chies, Jose Artur Bogo
    [J]. INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2024, 51 (01) : 20 - 31
  • [44] A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
    Kostrikis, LG
    Huang, YX
    Moore, JP
    Wolinsky, SM
    Zhang, LQ
    Guo, Y
    Deutsch, L
    Phair, J
    Neumann, AU
    Ho, DD
    [J]. NATURE MEDICINE, 1998, 4 (03) : 350 - 353
  • [45] A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
    Leondios G. Kostrikis
    Yaoxing Huang
    John P. Moore
    Steve M. Wolinsky
    Linqi Zhang
    Yong Guo
    Lisa Deutsch
    John Phair
    Avidan U. Neumann
    David D. Ho
    [J]. Nature Medicine, 1998, 4 : 350 - 353
  • [46] Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry
    Nahabedian, John
    Sharma, Amit
    Kaczmarek, Maryska E.
    Wilkerson, Greg K.
    Sawyer, Sara L.
    Overbaugh, Julie
    [J]. VIROLOGY, 2017, 512 : 180 - 186
  • [47] CCR5 cell surface density and HIV-1 envelope sequences govern antiretroviral potency of CCR5 antagonists
    Miller, MD
    Lineberger, JE
    Dornadula, G
    Danzeisen, RC
    Blau, CR
    Danovich, RM
    Miller, MA
    Finke, PE
    Oates, BD
    Caldwell, CG
    Chen, P
    Meurer, LC
    Mills, SG
    Springer, MS
    Petropoulos, CJ
    Whitcomb, J
    Huang, W
    Fransen, S
    Simon, AJ
    Hazuda, DJ
    [J]. ANTIVIRAL THERAPY, 2003, 8 (03) : U66 - U67
  • [48] Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients
    Soulie, Cathia
    Malet, Isabelle
    Lambert-Niclot, Sidonie
    Tubiana, Roland
    Thevenin, Monique
    Simon, Anne
    Murphy, Robert
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    [J]. AIDS, 2008, 22 (16) : 2212 - 2214
  • [49] Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists
    Henrich, Timothy J.
    Lewine, Nicolas R. P.
    Lee, Sun-Hee
    Rao, Suhas S. P.
    Berro, Reem
    Gulick, Roy M.
    Moore, John P.
    Tsibris, Athe M. N.
    Kuritzkes, Daniel R.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) : 1931 - 1935
  • [50] Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES
    Nardese, V
    Longhi, R
    Polo, S
    Sironi, F
    Arcelloni, C
    Paroni, R
    DeSantis, C
    Sarmientos, P
    Rizzi, M
    Bolognesi, M
    Pavone, V
    Lusso, P
    [J]. NATURE STRUCTURAL BIOLOGY, 2001, 8 (07): : 611 - 615